JAMA
Original Investigation
April 6, 2024
Richard M.ÌýMartin, BM, BS, PhD; Emma L.ÌýTurner,Ìý±Ê³ó¶Ù; Grace J.ÌýYoung, MSc; Chris Metcalfe,Ìý±Ê³ó¶Ù; Eleanor I.ÌýWalsh, MSc; J. Athene Lane,Ìý±Ê³ó¶Ù; Jonathan A. C.ÌýSterne,Ìý±Ê³ó¶Ù; Sian Noble,Ìý±Ê³ó¶Ù; Peter Holding, MSc; Yoav Ben-Shlomo, MBBS, PhD; Naomi J.ÌýWilliams,Ìý±Ê³ó¶Ù; Nora Pashayan, MD, PhD; Mai Ngoc Bui,Ìý±Ê³ó¶Ù; Peter C.ÌýAlbertsen, MD; Tyler M.ÌýSeibert, MD, PhD; Anthony L.ÌýZietman, MD; Jon Oxley, MD; Jan Adolfsson, MD; Malcolm D.ÌýMason, MD; George Davey Smith, DSc; David E.ÌýNeal, MD; Freddie C.ÌýHamdy, MD; Jenny L.ÌýDonovan,Ìý±Ê³ó¶Ù; CAP Trial Group
is active quiz
has multimedia
JAMA. 2024; 331(17):1460-1470. 10.1001/jama.2024.4011
This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Statistics and Research Methods
September 27, 2023
Harrison J.ÌýHansford, BSc(Hons); Aidan G.ÌýCashin,Ìý±Ê³ó¶Ù; Matthew D.ÌýJones,Ìý±Ê³ó¶Ù; Sonja A.ÌýSwanson, ScD; Nazrul Islam, MD, PhD; Susan R. G.ÌýDouglas, BExPhys; Rodrigo R. N.ÌýRizzo,Ìý±Ê³ó¶Ù; Jack J.ÌýDevonshire, BSc(Hons); Sam A.ÌýWilliams, BSc(Hons); Issa J.ÌýDahabreh, MD, ScD; Barbra A.ÌýDickerman,Ìý±Ê³ó¶Ù; Matthias Egger, MD, MSc; Xabier Garcia-Albeniz, MD, PhD; Robert M.ÌýGolub, MD; Sara Lodi,Ìý±Ê³ó¶Ù; Margarita Moreno-Betancur,Ìý±Ê³ó¶Ù; Sallie-Anne Pearson,Ìý±Ê³ó¶Ù; Sebastian Schneeweiss, MD, ScD; Jonathan A. C.ÌýSterne,Ìý±Ê³ó¶Ù; Melissa K.ÌýSharp,Ìý±Ê³ó¶Ù; Elizabeth A.ÌýStuart,Ìý±Ê³ó¶Ù; Miguel A.ÌýHernán, MD, DrPh; Hopin Lee,Ìý±Ê³ó¶Ù; James H.ÌýMcAuley,Ìý±Ê³ó¶Ù
open access
ÁñÁ«ÊÓƵ Netw Open. 2023; 6(9):e2336023. 10.1001/jamanetworkopen.2023.36023
This systematic review assesses the reporting of observational studies that explicitly aimed to emulate target trials, hypothetical randomized trials that could answer causal questions of interest.
JAMA Cardiology
Viewpoint
October 1, 2018
Luke A.ÌýMcGuinness, MSc; Julian P. T.ÌýHiggins,Ìý±Ê³ó¶Ù; Jonathan A. C.ÌýSterne,Ìý±Ê³ó¶Ù
JAMA Cardiol. 2018; 3(10):905-906. 10.1001/jamacardio.2018.2267
This Viewpoint presents the Risk Of Bias In Nonrandomized Studies of Interventions tool, which permits researchers to compare nonrandomized studies with hypothetical randomized clinical trials.
JAMA
Original Investigation
March 6, 2018
Richard M.ÌýMartin,Ìý±Ê³ó¶Ù; Jenny L.ÌýDonovan,Ìý±Ê³ó¶Ù; Emma L.ÌýTurner,Ìý±Ê³ó¶Ù; Chris Metcalfe,Ìý±Ê³ó¶Ù; Grace J.ÌýYoung, MSc; Eleanor I.ÌýWalsh, MSc; J. Athene Lane,Ìý±Ê³ó¶Ù; Sian Noble,Ìý±Ê³ó¶Ù; Steven E.ÌýOliver,Ìý±Ê³ó¶Ù; Simon Evans, MD; Jonathan A. C.ÌýSterne,Ìý±Ê³ó¶Ù; Peter Holding, MSc; Yoav Ben-Shlomo,Ìý±Ê³ó¶Ù; Peter Brindle, MD; Naomi J.ÌýWilliams,Ìý±Ê³ó¶Ù; Elizabeth M.ÌýHill, MSc; Siaw Yein Ng,Ìý±Ê³ó¶Ù; Jessica Toole, MSc; Marta K.ÌýTazewell, MSc; Laura J.ÌýHughes, BA; Charlotte F.ÌýDavies,Ìý±Ê³ó¶Ù; Joanna C.ÌýThorn,Ìý±Ê³ó¶Ù; Elizabeth Down, MSc; George Davey Smith, DSc; David E.ÌýNeal, MD; Freddie C.ÌýHamdy, MD; CAP Trial Group
free access
JAMA. 2018; 319(9):883-895. 10.1001/jama.2018.0154
This cluster randomized trial evaluates the effect of a single prostate-specific antigen (PSA) screening test on 10-year prostate cancer–specific mortality among men aged 50 to 69 years treated at UK primary care practices.
JAMA Internal Medicine
Review
April 24, 2006
Colette M. Reid, MB; Richard M. Martin, BM, PhD; Jonathan A. C. Sterne, PhD; Andrew N. Davies, MD; Geoffrey W. Hanks, DSc
free access
Arch Intern Med. 2006; 166(8):837-843. 10.1001/archinte.166.8.837